February 13, 2025

FDA Approves Extended Label for Avacincaptad Pegol

The new label removes limitations on the duration of dosing.

Conexiant

February 03, 2025

EssilorLuxottica Receives FDA Clearance for Nuance Audio Smart Glasses

Sales are expected to begin in the United States in Q1, and in Italy, France, Germany, and the United Kingdom in the first half of 2025.

Conexiant

January 27, 2025

Long-Term Effects of COVID-19 Reinfections

“Each subsequent infection could potentially increase the burden on the immune system, leaving individuals vulnerable to the cumulative effects of the virus."

Conexiant

January 27, 2025

CIA Shifts Stance on COVID-19 Origins

"Now, the most important thing is to make China pay for unleashing a plague on the world."

Conexiant

August 27, 2024

PCPs Play Important Role in Glaucoma Screening

“Recommendations from trusted primary providers have likely kept millions of individuals from becoming blind.”

Conexiant

January 16, 2025

LA County Fires Prompt Business Recovery Centers to Open

"Business owners can meet face-to-face with specialists to apply for disaster loans and access a wide range of resources to guide them through their recovery."

Optometric Management

August 15, 2024

Major Medicare Drug Price Cuts Announced

Biden administration secures up to 79% in reductions on top-selling medications.

Reuters

November 07, 2024

Diabetes Affects 1 in 6 US Adults: CDC Data

In a stark reflection of diabetes screening gaps, more than one-quarter of U.S. adults with diabetes remained undiagnosed in 2021-2023, with obesity linked to a nearly four-fold higher prevalence compared to normal-weight individuals.

Conexiant

December 16, 2024

Does Ozempic Double Eye Disease Risk?

Danish health authorities seek EU review of studies linking Novo Nordisk's Ozempic to rare eye condition in type 2 diabetes patients.

Reuters